CIK 0001835597
- Emerging growth company
PepGen Inc.
Sign in to watch- Ticker
- PEPG
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 703-456-8000
- Business address
- 1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, 02210
- 4 Grant or award General Counsel acquired 13,400 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 23,283 shares (grant or award)
- 4 Grant or award EVP, Head of R&D acquired 19,430 shares (grant or award)
- 4 Grant or award President and CEO acquired 60,719 shares (grant or award)
- 4 Open-market sale General Counsel sold 1,432 shares at $1.68 ($2,406)
- 4 Open-market sale Chief Financial Officer sold 1,527 shares at $1.68 ($2,565)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Medical Officer sold 7,772 shares at an average $18.06 ($140,360)
- 4 Planned sale Chief Medical Officer sold 12,625 shares at $18.20 ($229,804)
- 4 Planned sale Chief Medical Officer sold 9,189 shares at an average $18.02 ($165,578)
- 4 Planned sale Chief Medical Officer sold 912 shares at an average $18.01 ($16,428)
- 4 Planned sale Chief Medical Officer sold 9,260 shares at $18.19 ($168,427)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 7 · 122 filings